Mandate

Vinge advises ITAB in connection with a recapitalisation of SEK 868 million

February 11, 2021 Capital Markets and Public M&A

The recapitalisation is carried out to strengthen ITAB’s capital structure to reduce the financial leverage of the group, to invest in the One ITAB transformation plan and to provide sufficient headroom to the business given the Covid-19 situation.

The recapitalisation entails that the equity is strengthened by approx. SEK 868 million by a rights issue of SEK 768 million and a set-off issue of SEK 100 million and entails further that Aeternum Capital becomes ITAB’s largest shareholder with a holding of approx. 25 percent of the shares. First day of trading in the new class B shares issued as a result of the recapitalisation is estimated to be 22 March 2021.

ITAB sells, develops, manufactures and installs complete shop fitting concepts for retail chain stores. The offer includes custom-made fitting concepts, innovative solutions for the checkout area, professional lighting systems and interactive products. Customers include major retail chains throughout most of Europe. ITAB’s class B shares are listed on Nasdaq Stockholm.

Vinge’s team mainly consisted of Charlotte Levin, Rikard Lindahl, Annika Nyberg Ekenberg, Clara Sohlberg, Mikaela Falkner, Henrik Wastenson and David Bokliden.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025